Admission Date:  [**2162-1-17**]              Discharge Date:   [**2162-1-23**]  Date of Birth:  [**2097-1-8**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 6021**] Chief Complaint: weakness, hypotension  Major Surgical or Invasive Procedure: IR percutaneous nephrostomy tube placement [**2162-1-18**]   History of Present Illness: Ms [**Name13 (STitle) 43791**] is a 64-year-old female with metastatic breast cancer, history of DVT, s/p recent ureteral stent placement ([**2162-1-12**])for left sided hydroureteronephrosis, who was transferred to the [**Hospital1 18**] with weakness, hypotension.
Upon arrival to the ED, the patient was found to be hypotensive with a BP of 94/37.
She received 2.5 L of NS with minimal improvement in her BP, and was started on Levophed for her hypotension.
CT scan of the abdomen and pelvis revealed possible mild diverticulitis, and her U/A was suggestive of UTI.
She has had no evidence of active bleeding.
She has been maintained on dilaudid PCA for back pain and plan was to wean off 12 hrs after placement of fentanyl patch (she was found to have 2 patches on by nursing, both of which were removed and new patch placed at 8 pm [**1-19**].
She has only minimal PCA requirements at this time.
She also notes R knee pain with movement.
Past Medical History: # metastatic breast cancer s/p chemo, XRT, 5 years tamoxifen, arimidex, Cyberknife, Xeloda, Zometa # Left-sided hydroureteronephrosis with a question of mass at the left ureter s/p ureteral stent placement [**2162-1-12**] # DVT treated with lovenox [**2161-2-19**] # Right total knee replacement # HTN # s/p Thyroidectomy # s/p Cholecystectomy .
Onc History: She was diagnosed with left-sided breast cancer with lumpectomy and axillary lymph node dissection 12 years ago.
She had stage II disease and was treated with adjuvant radiation therapy and chemotherapy and five years of tamoxifen.
She later had a mastectomy, which had no evidence of residual disease.
In [**8-/2159**], she presented with bone metastases and diffuse lymphadenopathy.
A lymph node biopsy of a left supraclavicular node confirmed metastatic disease on [**2159-10-1**].
Family History: NC  Physical Exam: T: 96.1 BP: 102/57 HR: 80 RR: 20 O2 97% RA Gen: Pleasant, well appearing female in NAD HEENT: No conjunctival pallor.
2+ DP pulses BL MSK: + R knee effusion with pain on active and passive ROM SKIN: No rashes/lesions, ecchymoses.
Colonic diverticulosis with minimal perisigmoid inflammatory fat strand to suggest uncomplicated diverticulitis.
Persistent left hydroureteronephrosis with indwelling internal nephrostomy stent.
There is high attenuation layering in the dilated left collecting system, this may represent debris, infection or hemorrhage.
No significant change in appearance of known osseous metastases.
It was felt to be urosepsis from pyelonephritis.
A CT scan demonstrated stranding and possible infection in the collecting system of her recently stented kidney.
She did not improve during the first 24 hours of her admission, and was unable to wean from levophed.
She was continued on vancomycin, ceftriaxone and cipro, double coverage for possible gram negatives and pseudomonas.
She was called out to Oncology service for continued management of metastatic breast cancer with bony mets.
# Urosepsis ?
However, CT does demonstrate high attenuation focus which could be infection - consequently continued Cipro for 10 day course.
# L hydronephrosis: CT Abdomen [**10-17**] new L hydronephrosis with transition point mid ureter -> concerning for metastasis left ureter.
CT abdomen [**1-18**] persistent L hydroureteronephrosis indwelling internal nephrostimy stent.
High attenuation dilated L collecting - diff includes debris, infection, hemorrhage.
# Anemia: Most likely secondary to hematuria, serosangiunous draining from PTC.
# Knee Pain: Chronic plus recent trauma.
Continue outpatient pain medications.
# Breast Cancer: s/p multiple rounds of chemo, hormonal therapy, XRT, and Cyberknife.
# h/o DVT: Diagnosed [**2161-2-19**].
[**Month (only) 116**] be re-started as outpatient is blood pressure increases.
# Hyperlididemia: Continued statin   Medications on Admission: CAPECITABINE [XELODA] - 1500 mg in am, 1000mg in pm ENOXAPARIN [LOVENOX] - 120 mg/0.8 mL Syringe qd FENTANYL [DURAGESIC] - 75 mcg/hour Patch 72 hr - 1 patch TD q 72 hours LOVASTATIN - (Prescribed by Other Provider) - 40 mg qhs NYSTATIN - 100,000 unit/mL Suspension - 5 mL Suspension(s) by mouth four times a day Swish OMEPRAZOLE [PRILOSEC] - 20 mg [**Hospital1 **] OXYCODONE - 5 mg q 3-4 hours prn pain PROCHLORPERAZINE EDISYLATE [COMPAZINE] - 10 mg q8hrs prn nausea VALSARTAN [DIOVAN] - 160 mg qd ZOLEDRONIC ACID [ZOMETA] - (infusion in clinic) - 4 mg/5 mL Solution - monthly ACETAMINOPHEN [TYLENOL] - 325 mg by mouth daily MULTIVITAMINS-MINERALS-LUTEIN [CENTRUM SILVER] SENNOSIDES-DOCUSATE SODIUM [PERI-COLACE] - 8.6 mg-50 mg [**Hospital1 **] .
Polyethylene Glycol 3350 100 % Powder Sig: One (1)  PO DAILY (Daily) as needed for constipation.
Discharge Disposition: Extended Care  Facility: Bay [**Hospital **] Rehab  Discharge Diagnosis: Breast Cancer L hydronephrosis Anemia, hematuria Possible urosepsis   Discharge Condition: Good, ambulating, stable BP.
Discharge Instructions: You were admitted for low blood pressure and weakness.
Return to the ER if you experience fever, chills, abdominal pain, difficulty breathing, passing out or other concerning symptoms.
